Boyd Biomedical’s Post

With a focus on the individual you can concentrate care options for the best results. See how Michael and his company's approach to patient-centric care has changed the landscape of the biomedical manufacturing world.

Can biomedical innovators actually be patient-centric? Does it require an altogether more pateint-centric ecosystem? Clinical trials, regulatory, care settings...supply chains? Michael Chiu outlines the approach to a more patient-centric manufacturing ecosystem as envisioned by Erbi Biosystems, a part of MilliporeSigma.

In our latest article for ONdrugDelivery, Biomedical Market Manager Landon Goldfarb highlights the challenges of autoinjector testing and the importance of drawing on the experience of customers when it comes to drug delivery device innovation: https://lnkd.in/dk4CAHzg

Juggling 15+ systems for ONE clinical trial is crazy! Our webcast (ft. GSK, Medable, & Alcanza Research) dives into how a unified platform can streamline e-stuff (Consent, COA, etc.) & sensor data for a smooth, end-to-end ride. Level up your research game! Watch Video: https://lnkd.in/gMPBeSk6 #pharmaindustry #digitaltransformation #clinicaltrials #digitaltrials #pharmaceuticaltechnology

Digital twins can transform life sciences R&D. Improve drug discovery, optimize manufacturing, and personalize patient care. https://hubs.la/Q01SlDSM0

Check out Key Tech Inc.‘s approach for evaluating assays for automation! If you're developing an IVD device or life science tool, this #Framework is definitely worth referencing. https://lnkd.in/d6GFiYdr Originally written in 2021 & geared to de-risking platforms, we tend to view it now from a more positive, market-launch perspective. How can you step-change your consumable or instrument cost, differentiate from competition, and successfully exit to a strategic? I like thinking about it more positively 😃 Give it a read and see for yourself! #AssayAutomation #LifeScience #IVD #KeyTechInc

#ausbiotech2024 #medicaldevices #CE #ISO13485 #mdsap Come chat with us towards your device journey into global market #commercialisation

Selecting the right CDMO for assay development can be a complex process - but it doesn't have to be! In our latest blog, we break down 10 key considerations to help you make informed decisions and accelerate your journey to market. Whether you’re developing a novel diagnostic or scaling up a complex assay, we’ve got you covered. Discover how the right partner can enhance your assay development from concept to commercialisation. 👉 Read the full blog here https://lnkd.in/e4nZPWP8 #AssayDevelopment #CDMO #Research #Manufacturing

💊 The March/April edition of European Pharmaceutical Manufacturer is now LIVE: - At the editor's desk, Jai Mcintosh looks at spring budgets and Wegovy once gain. - A small dose: covering the latest big pharma developments. - Nigel Smith, CEO, TM Robotics, explores how advanced automation is shaping the future of medical device production. - Cover Story: Nandu Deorkar, Ph.D., and George Marquez, MBA, LSSBB of Avantor discuss advancing clinical trials manufacturing from pilot to production. - Paul Knight, Managing Director, CME Automation Systems Ltd postulates on how to implement automated ‘just-in-time’ clinical supply chains. - Comment Section: Following Chancellor of the Exchequer Jeremy Hunt’s Spring Budget, we spoke with voices across the industry to get their thoughts on how this budget will impact the world of UK pharma. - Mike Ludlow, Market Development Manager, Element Materials Technology looks at the factors to consider in critical assessment of contract research organisations. - Didier Haguenauer M.D., CMO, CellProthera SAS covers optimising time-to-market for innovative cell therapy trials. - Q&A: We caught up with Lonza once again, this time touching on artificial intelligence and machine learning. - Miroslav Hlaučo, Apheresis Network Manager, SCTbio, highlights the key considerations for effective apheresis cell collection. Check out the issue here: https://bit.ly/3VOJois #EPM #pharma

💊 The March/April edition of European Pharmaceutical Manufacturer is now LIVE: - At the editor's desk, Jai Mcintosh looks at spring budgets and Wegovy once gain. - A small dose: covering the latest big pharma developments. - Nigel Smith, CEO, TM Robotics, explores how advanced automation is shaping the future of medical device production. - Cover Story: Nandu Deorkar, Ph.D., and George Marquez, MBA, LSSBB of Avantor discuss advancing clinical trials manufacturing from pilot to production. - Paul Knight, Managing Director, CME Automation Systems Ltd postulates on how to implement automated ‘just-in-time’ clinical supply chains. - Comment Section: Following Chancellor of the Exchequer Jeremy Hunt’s Spring Budget, we spoke with voices across the industry to get their thoughts on how this budget will impact the world of UK pharma. - Mike Ludlow, Market Development Manager, Element Materials Technology looks at the factors to consider in critical assessment of contract research organisations. - Didier Haguenauer M.D., CMO, CellProthera SAS covers optimising time-to-market for innovative cell therapy trials. - Q&A: We caught up with Lonza once again, this time touching on artificial intelligence and machine learning. - Miroslav Hlaučo, Apheresis Network Manager, SCTbio, highlights the key considerations for effective apheresis cell collection. Check out the issue here: https://bit.ly/3VOJois #EPM #pharma